MindWalk Holdings Corp.

NASDAQ:HYFT

Biotechnology

Healthcare
$1.08 +0.33%

+$0.01 today

Market cap
$50.88M
Beta
0.82
P/E (TTM)
-8.1
EPS (TTM)
-$0.26
52W Low $0.82High $3.25

Volume 0.20M

Average 0.32M

HYFT Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

MindWalk Holdings Corp.NASDAQ: HYFT

Stock-Based Compensation · Q3 FY2026 · quarter ended Jan 2026

Stock-based compensation outflow shrinks to CA$0

Q3 FY2026 stock-based compensation was CA$0, compared with CA$70K a year earlier. Trailing-twelve-month stock-based compensation was CA$260K. Over 3 fiscal years it compounded at -47.5% a year.

Context

  • Stock-based compensation amounted to 1.8% of revenue in FY2025, down 4.4 pp from a year earlier.
  • Stock-based compensation increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly stock-based compensation holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$65K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJan 2026
CA$0-100.0% QoQ
Last fiscal yearApr 2025
CA$445K-71.0% YoY
LTMJan 2026
CA$260K-58.7% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year-71.0%——
3-year CAGR-47.5%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

CAD · from the cash flow

Latest · FY2025
445K CAD
Year-over-year change
-71.0%
4-year CAGR
-36.6%

Stock-Based Compensation vs competitors

How HYFT compares with its peers on the latest reported figures

  • Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -58.7% is the 7th highest of 8, against a peer median of -12.1%.
  • Stock-based compensation amounts to 1.4% of revenue for HYFT, versus a peer median of 1407.5%.
HYFT Competitors
Stock-Based Compensation for HYFT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FBIOFortress Biotech, Inc.LTM Mar 2026$22.45M USD-34.1%+7.7%33.9%
ALXOALX Oncology Holdings Inc.LTM Mar 2026$9.87M USD-60.9%-19.2%—
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$7.81M USD-26.4%+28.7%—
CLNNClene Inc.LTM Mar 2026$7.45M USD-5.5%-9.2%5559.7%
ATYRaTyr Pharma, Inc.LTM Mar 2026$5.13M USD+49.6%+32.4%2697.9%
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026$4.61M USD+14.2%—117.2%
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026$2.1M USD-12.1%+36.1%—
HYFTMindWalk Holdings Corp.LTM Jan 2026CA$260K CAD-58.7%-47.5%1.4%
BYSIBeyondSpring Inc.LTM Mar 2026$145K USD———
Peer median (excluding HYFT) —-12.1%+18.2%1407.5%

Competitors are the stored peer set for HYFT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Apr 2021
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
Net Income(7.34M)(16.71M)(26.56M)(27.18M)(30.23M)
Depreciation & Amortization3.71M3.77M6.69M5.74M5.12M
Deferred Income Tax(83K)(336K)(926K)(1.77M)(3.94M)
Stock-Based Compensation2.75M3.08M1.94M1.54M445K
Change in Working Capital(1.02M)582K(3.28M)2.4M276.99K
Accounts Receivables(439K)163K(561K)(241K)(391.8K)
Inventory(316K)(501K)(185K)(102K)99.03K
Accounts Payables(73K)781K(1.55M)994.8K593.45K
Other Working Capital(190K)139K(976K)1.75M(23.68K)
Other Non-Cash Items1.38M(310K)2.3M15.03M21.92M
Operating Cash Flow(600K)(9.92M)(19.83M)(4.25M)(6.41M)
Capital Expenditures(1.43M)(1.26M)(1.5M)(1.4M)(799K)
Acquisitions (Net)(1.03M)(3.69M)(592K)(146K)0
Purchases of Investments00000
Sales of Investments0080K121K0
Other Investing Activities0(259K)40K(141K)0
Investing Cash Flow(2.46M)(5.21M)(1.97M)(1.56M)(799K)
Debt Repayment(772K)(962K)(1.34M)(1.34M)2.67M
Common Stock Issued44.15M3.85M716K1.75M12.23M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities0(5K)0612.26K0
Financing Cash Flow43.38M2.88M(621K)1.02M14.89M
Effect of Forex Changes(1.18M)455K740K(33K)(438K)
Net Change in Cash39.15M(11.79M)(21.68M)(4.82M)7.25M
Free Cash Flow(2.03M)(11.18M)(21.33M)(5.64M)(7.21M)

MindWalk Holdings Corp.

NASDAQ:HYFT

Intrinsic Alpha fair value

Locked

Current Price

$1.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.